Skip to content

Clinical trials

Phase 2 Psoriasis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psoriasis Phase: Phase 2 Country / region: Germany Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20064
20071
20081
20092
20101
20115
20122
20132
20142
20152
20164
20171
20184
20198
20202
20212
20222
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Terminated3
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim9
Almirall, S.A.5
LEO Pharma4
Amgen2
Aristea Therapeutics, Inc.2
MetrioPharm AG2
Novartis Pharmaceuticals2
Stiefel, a GSK Company2
Vascular Biogenics Ltd. operating as VBL Therapeutics2
Zalicus2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psoriasis51
Arthritis, Psoriatic3
Skin Diseases3
Bronchiolitis Obliterans Syndrome2
Lymphoma, Follicular2
Plaque, Amyloid2
Pruritus2
Arthritis1
Dermatitis1
Erythema1

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.